Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
VERO 
Venus Concept Inc (VERO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: VERO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -81.3% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.73M USD | Price to earnings Ratio - | 1Y Target Price 10.6 |
Price to earnings Ratio - | 1Y Target Price 10.6 | ||
Volume (30-day avg) 113211 | Beta 0.53 | 52 Weeks Range 2.33 - 14.74 | Updated Date 04/1/2025 |
52 Weeks Range 2.33 - 14.74 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -87.67 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-31 | When Before Market | Estimate -10.01 | Actual -11.23 |
Profitability
Profit Margin -74.62% | Operating Margin (TTM) -47.69% |
Management Effectiveness
Return on Assets (TTM) -20.55% | Return on Equity (TTM) -463.54% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 35705200 | Price to Sales(TTM) 0.03 |
Enterprise Value 35705200 | Price to Sales(TTM) 0.03 | ||
Enterprise Value to Revenue 0.53 | Enterprise Value to EBITDA -3.16 | Shares Outstanding 659570 | Shares Floating 486922 |
Shares Outstanding 659570 | Shares Floating 486922 | ||
Percent Insiders 5.49 | Percent Institutions 29.32 |
Analyst Ratings
Rating 3 | Target Price 10.6 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 3 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Venus Concept Inc
Company Overview
History and Background
Venus Concept Inc. was founded in 2009. It develops, commercializes, and delivers aesthetic technologies. It has grown through product innovation and strategic acquisitions.
Core Business Areas
- Aesthetic Devices: Develops and markets non-invasive medical aesthetic devices for skin tightening, body contouring, hair removal, and acne treatment. These devices utilize various energy-based technologies.
- Consumables: Sells consumables used in conjunction with its aesthetic devices, generating recurring revenue.
- Service and Support: Provides service and support for its devices, including training and maintenance.
Leadership and Structure
The leadership team consists of experienced executives in the medical device and aesthetics industries. Organizational structure includes sales, marketing, R&D, and operations departments.
Top Products and Market Share
Key Offerings
- Venus Legacy: A multi-polar radio frequency device used for non-invasive body contouring, skin tightening, and cellulite reduction. Competitors include Cutera and BTL Aesthetics. Market share data is not publicly available for specific products but is incorporated in the overall market share
- Venus Versa: A multi-application platform for skin resurfacing, hair removal, acne treatment, and photorejuvenation. Competitors include Lumenis and Cynosure. Market share data is not publicly available for specific products but is incorporated in the overall market share.
- Venus Viva: A fractional radio frequency system for skin resurfacing and scar reduction. Competitors include Lutronic and Endymed. Market share data is not publicly available for specific products but is incorporated in the overall market share.
Market Dynamics
Industry Overview
The medical aesthetics market is growing due to increasing demand for non-invasive cosmetic procedures, aging population, and technological advancements.
Positioning
Venus Concept positions itself as a provider of affordable and versatile aesthetic solutions for clinics and practitioners, focusing on user-friendliness and cost-effectiveness. The company's competitive advantage lies in its multi-application platforms and subscription based business model.
Total Addressable Market (TAM)
The global medical aesthetics market is projected to reach $24.5 billion by 2027. Venus Concept is positioned to capture a share of this TAM through its range of non-invasive aesthetic devices and consumables.
Upturn SWOT Analysis
Strengths
- Diverse product portfolio
- Established brand reputation
- Subscription-based business model
- Global distribution network
- Focus on affordable solutions
Weaknesses
- Limited profitability
- High operating expenses
- Intense competition
- Dependence on device sales
- Limited financial resources
Opportunities
- Expanding into new markets
- Developing innovative technologies
- Acquiring complementary businesses
- Increasing awareness of aesthetic procedures
- Partnering with key opinion leaders
Threats
- Economic downturns
- Regulatory changes
- Technological obsolescence
- Increased competition
- Product liability claims
Competitors and Market Share
Key Competitors
- LMNR
- CYNO
- ALGN
Competitive Landscape
Venus Concept faces intense competition from established players in the aesthetic device market. It needs to differentiate itself through innovation and cost-effectiveness.
Major Acquisitions
NeoGraft
- Year: 2018
- Acquisition Price (USD millions): 15
- Strategic Rationale: Expanded Venus Concept's product portfolio into hair restoration.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by product launches and market expansion. However, profitability has been a challenge.
Future Projections: Future growth is projected to be driven by increased demand for aesthetic procedures and the company's continued innovation. Analyst estimates unavailable without access to real-time data sources.
Recent Initiatives: Recent initiatives include new product launches, expansion into new markets, and strategic partnerships.
Summary
Venus Concept has a diverse product portfolio and a global distribution network but struggles with profitability due to high operating costs and intense competition. It's subscription based business model and focus on affordability gives it advantages. The company needs to improve its financial performance while continuing to innovate and expand into new markets. Investors should watch for profitability improvements and increased market share.
Similar Companies
ALGN
Align Technology Inc
ALGN
Align Technology Inc
LMNR
Limoneira Co
LMNR
Limoneira Co
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
- Market research reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Data may be subject to change and is based on publicly available information. Market share estimates are approximate and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Venus Concept Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2012-11-05 | CEO & Director Mr. Rajiv Kanishka Liyanaarchchie De Silva | ||
Sector Healthcare | Industry Medical Devices | Full time employees 304 | Website https://www.venus.ai |
Full time employees 304 | Website https://www.venus.ai | ||
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.